The North Carolina Translational and Clinical Sciences (NC TraCS) Institute, combines the research strengths, resources and opportunities of UNC, partner institution RTI International (RTI) and planning partner North Carolina Agricultural and Technical State University (N.C. A&T).
The mission of NC TraCS is to accelerate clinical and translational research from health science to discovery to dissemination to patients and communities. It seeks to overcome barriers to translation by improving efficiency, training the research workforce and sharing successful research methods.
As the integrated home of the Clinical and Translational Science Awards (CTSA) program at UNC-CH, NC TraCS is supported through the National Institutes of Health (NIH), grant 1UL1TR001111. The CTSA program is led by the NIH’s National Center for Advancing Translational Sciences (NCATS).
NC TraCS aims to:
- Expand to support the full spectrum of clinical and translational research.
- Focus on three strategic initiatives: next-generation technologies to transform clinical research and practice, new paradigms and resources to accelerate drug development, and comparative-effectiveness research to provide definitive evidence of the benefits and harms of tests and treatments.
- Train, support and motivate the next generation of clinical and translational researchers.
The unique research and training resources at NC TraCS will support the full range of clinical and translational research, from basic science to clinical application to policy change, to benefit patients across the state and nationally through the CTSA Consortium.Visit NC TraCS
Additional News/Resources:UNC Healthcare/School of Medicine Newsroom
National Institutes of Health
Dr. Francis Collins (NIH Director)
RTI International Newsroom
About the CTSA Consortium